ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Oral Microbes and Host

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1564891

This article is part of the Research TopicImpact of oral and gut microbiome on health and diseasesView all 15 articles

Salivary Mycobiome Alterations in HIV-Infected MSM: Dominance of Pseudogymnoascus and Functional Shifts Across Disease Stages

Provisionally accepted
Ying  GuoYing Guo1,2Lu  LinLu Lin1Miao  ZhangMiao Zhang1Yixi  YuYixi Yu1Wang  YanWang Yan1Jie  CaoJie Cao1Li  YuchenLi Yuchen1Xintong  SunXintong Sun1Meilin  GuanMeilin Guan1Wen  ShuoWen Shuo1Xin  WangXin Wang1Zhen  FangZhen Fang3Wenshan  DuanWenshan Duan3Junyi  DuanJunyi Duan3Tao  HuangTao Huang3Wei  XiaWei Xia3Shan  GuoShan Guo2Feili  WeiFeili Wei2Dongxiang  ZhengDongxiang Zheng1Xiaojie  HuangXiaojie Huang3*
  • 1Department of Stomatology, Beijing Youan Hospital, Capital Medical University, Beijing, China
  • 2Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing City, China
  • 3Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China

The final, formatted version of the article will be published soon.

Background: Oral health is increasingly recognized as a crucial determinant of overall health in people living with HIV/AIDS (PLWHA). Specifically, the oral mycobiome may play a pivotal role in HIV-associated oral complications. However, the fungal species involved and their potential as biomarkers for HIV-related oral conditions remain poorly understood. This study investigates salivary fungal profiles in PLWHA who have sex with men (MSM), focusing on diversity, functional shifts, and correlations with disease progression.Methods: A cross-sectional study included 25 MSM participants divided into five groups: HIV-negative controls (n = 5) and four HIV-positive groups stratified by CD4 count: Stage 0 (HIV RNA-positive/antibody-negative; n = 5), Stage 1 (CD4 ≥500 cells/μL; n = 5), Stage 2 (CD4 200–499 cells/μL; n = 5), and Stage 3 (CD4 <200 cells/μL or opportunistic infections; n = 5). Saliva samples were collected and analyzed using metagenomic sequencing (Illumina NovaSeq platform). Bioinformatic analyses included genome assembly (MEGAHIT), gene clustering (CD-HIT), gene abundance calculation (SOAPaligner), species annotation (BLASTP), and KEGG pathway annotation (KOBAS 2.0). Statistical analyses (Kruskal-Wallis tests, Spearman’s correlation) assessed associations between fungal profiles, CD4 count, and viral loads.Results: A total of 51 fungal genera were identified, with Pseudogymnoascus being the most abundant. Functional analysis revealed 113 shared KEGG pathways, of which 69 were unique to Stage 3, primarily related to metabolic and disease-related processes. Notably, Auricularia exhibited a positive correlation with CD4 count (P ≤ 0.01), while Mucor showed a negative correlation (P = 0.0299). Conclusions: Salivary mycobiome composition and function shift significantly across HIV stages, reflecting immune decline. Pseudogymnoascus dominance challenges conventional views of oral fungal ecology in immunocompromised hosts. These findings highlight the mycobiome’s diagnostic potential for monitoring HIV-related oral health. Longitudinal studies are needed to validate clinical relevance.

Keywords: Saliva, Mycobiome, PLWHA, MSM, Metagenomic analyses, KEGG function

Received: 22 Jan 2025; Accepted: 17 Apr 2025.

Copyright: © 2025 Guo, Lin, Zhang, Yu, Yan, Cao, Yuchen, Sun, Guan, Shuo, Wang, Fang, Duan, Duan, Huang, Xia, Guo, Wei, Zheng and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiaojie Huang, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.